BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Business

  Lilly Confirms Date and Conference Call for Third-Quarter 2023 Financial Results Announcement

  Eli Lilly and Company (NYSE: LLY) will announce its third-quarter 2023 financial results on Thursday, Nov. 2, 2023.

  October 20, 2023

   · 

  1 min read
• Abivax Announces Trading Resumption of its Ordinary Shares on Euronext Paris

  Abivax SA announced the trading resumption of its ordinary shares on Euronext in Paris as from 4:20 p.m. CEST.

  October 20, 2023

   · 

  4 min read
• Drug Development

  Merck’s KEYTRUDA® (pembrolizumab) Plus Concurrent Chemoradiotherapy Significantly Improved Progression-Free Survival (PFS) Versus Concurrent Chemoradiotherapy Alone in Newly Diagnosed, High-Risk Locally Advanced Cervical Cancer

  Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from the pivotal Phase 3 KEYNOTE-A18 trial, also known as ENGOT-cx11/GOG-3047, investigating KEYTRUDA.

  October 20, 2023

   · 

  53 min read
• Genetown

  Velico Medical launches Blood Center Education Program with South Texas Blood & Tissue

  Velico Medical is proud to announce the launch of its Blood Center Education Program (BCEP) at South Texas Blood & Tissue (STB&T), a subsidiary of San Antonio non-profit BioBridge Global.

  October 20, 2023

   · 

  3 min read
• Research Conducted by Florida Cancer Specialists & Research Institute Featured at European Society of Medical Oncology 2023 Congress

  Research conducted by Florida Cancer Specialists & Research Institute, LLC (FCS) is featured this week among the latest advancements and findings in cancer care at the European Society of Medical Oncology (ESMO) Congress in Madrid, Spain.

  October 20, 2023

   · 

  4 min read
• StageZero Life Sciences’ Clinical Business Introduces Third Pillar to Cancer Offerings

  StageZero Life Sciences, Ltd. announces that its Clinical Business Care Oncology, has added the first of a series of new program offerings.

  October 20, 2023

   · 

  5 min read
• BioMidwest

  Why do some men not produce sperm? Stowers scientists collaborate to uncover one underlying reason for male infertility

  Millions of couples worldwide experience infertility with half of the cases originating in men. For 10% of infertile males, little or no sperm are produced.

  October 20, 2023

   · 

  5 min read
• Policy

  Mindset Pharma Announces Shareholder Approval of Arrangement

  Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”) is pleased to announce that further to its press releases of August 31, 2023 and September 22, 2023

  October 20, 2023

   · 

  4 min read
• American Aires Announces Debt Settlement and Equity Incentive Grants

  American Aires Inc. (CSE: WIFI) (OTC Pink: AAIRF) (“Aires” or the “Company”), a company focused on scientifically-proven EMF modulation technology, announces that it has entered into shares for debt settlement agreements dated October 17, 2023

  October 20, 2023

   · 

  6 min read
• Biotech Beach

  Skye Bioscience to Host Virtual Investor Day on October 25, 2023: “CB1 Axis: Unlocking the Pharmaceutical Potential of the Endocannabinoid System”

  Phase 1 clinical data to be released in conjunction with Investor Day

  October 20, 2023

   · 

  5 min read